Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,217 | 278 | 98.1% |
| Education | $99.95 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,634 | 100 | $0 (2024) |
| Janssen Biotech, Inc. | $1,064 | 52 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $501.29 | 32 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $355.99 | 17 | $0 (2024) |
| Celgene Corporation | $300.15 | 15 | $0 (2024) |
| QOL Medical, LLC | $273.75 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $147.94 | 8 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $125.00 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $117.31 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $111.09 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,229 | 66 | ABBVIE INC. ($463.81) |
| 2023 | $1,477 | 75 | ABBVIE INC. ($481.99) |
| 2022 | $1,422 | 67 | ABBVIE INC. ($409.17) |
| 2021 | $1,189 | 71 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($382.64) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/17/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Immunology | ||||||
| 10/07/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: LIVER DISEASE | ||||||
| 09/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Gastroenterology | ||||||
| 08/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 147 | 168 | $26,528 | $11,736 |
| 2022 | 6 | 230 | 266 | $34,966 | $15,549 |
| 2021 | 10 | 436 | 640 | $55,577 | $28,838 |
| 2020 | 9 | 612 | 770 | $59,466 | $26,127 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 89 | 100 | $19,400 | $8,391 | 43.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 41 | $4,264 | $2,094 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 14 | $1,876 | $834.24 | 44.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 13 | $988.00 | $416.39 | 42.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 74 | 80 | $15,520 | $6,715 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 39 | $5,226 | $2,565 | 49.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 35 | 35 | $5,040 | $2,228 | 44.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 48 | $4,992 | $2,144 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 24 | $2,160 | $1,122 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 12 | $1,608 | $693.00 | 43.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 22 | 28 | $420.00 | $81.35 | 19.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 159 | $21,306 | $12,353 | 58.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $9,196 | $4,110 | 44.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 76 | $6,840 | $3,976 | 58.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 29 | 159 | $6,327 | $3,771 | 59.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 23 | 23 | $3,312 | $1,434 | 43.3% |
| 99487 | Complex chronic care management services, first 60 minutes clinical staff time per calendar month | Office | 2021 | 21 | 25 | $2,165 | $928.24 | 42.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $2,040 | $841.63 | 41.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 17 | $1,768 | $781.32 | 44.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 88 | 109 | $1,635 | $322.60 | 19.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 13 | $988.00 | $320.06 | 32.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 187 | 259 | $23,354 | $10,861 | 46.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 104 | 130 | $17,420 | $8,036 | 46.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 38 | 38 | $5,168 | $2,195 | 42.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 39 | 43 | $4,292 | $2,019 | 47.0% |
About Joseph Richard, CFNP
Joseph Richard, CFNP is a Nurse Practitioner healthcare provider based in Mccomb, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700892346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joseph Richard, CFNP has received a total of $5,317 in payments from pharmaceutical and medical device companies, with $1,229 received in 2024. These payments were reported across 279 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($5,217).
As a Medicare-enrolled provider, Richard has provided services to 1,425 Medicare beneficiaries, totaling 1,844 services with total Medicare billing of $82,250. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Mccomb, MS
- Active Since 08/01/2006
- Last Updated 02/03/2017
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1700892346
Products in Payments
- STELARA (Biological) $783.32
- ZEPOSIA (Drug) $411.24
- XIFAXAN (Drug) $362.07
- Linzess (Drug) $355.99
- SKYRIZI (Biological) $324.19
- CREON (Drug) $310.92
- LINZESS (Drug) $288.85
- REMICADE (Biological) $287.95
- RINVOQ (Biological) $266.53
- VIBERZI (Drug) $233.34
- SUCRAID (Drug) $170.32
- HUMIRA (Biological) $158.84
- TREMFYA (Drug) $117.57
- DIFICID (Drug) $117.31
- TRULANCE (Drug) $110.29
- IBSRELA (Drug) $107.92
- Sucraid (Drug) $103.43
- GIMOTI (Drug) $88.01
- JARDIANCE (Drug) $83.93
- GATTEX (Drug) $79.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Mccomb
Misti Hedgepeth, Np-C, NP-C
Nurse Practitioner — Payments: $8,739
Candice Sumrall, Fnp, FNP
Nurse Practitioner — Payments: $7,566
Bonnie Hughes
Nurse Practitioner — Payments: $3,314
Frances Schmidt
Nurse Practitioner — Payments: $730.36
Mrs. Jennifer Stringer, Fnp, FNP
Nurse Practitioner — Payments: $607.87
Ellanie Bessonette, Agacnp, AGACNP
Nurse Practitioner — Payments: $275.77